A major vaccine shipment aims to confront the deadliest Ebola outbreak in Congo's history.
Outlets are counted by registrable domain, so a broadcaster’s station subdomains count once. 26 of the 28 items repeat an outlet already counted.
A major vaccine shipment aims to confront the deadliest Ebola outbreak in Congo's history.
More than 16,000 doses of the Ervebo Ebola vaccine arrived in the Democratic Republic of Congo on August 21.
This delivery is part of a larger batch of 70,000 doses allocated to the country from the global stockpile, the World Health Organization announced the previous day.
The country is facing what has been described as its deadliest and largest Ebola outbreak, officially declared in mid-May but suspected to have begun circulating earlier.
The Ervebo vaccine, produced by Merck, is approved for the Zaire strain of Ebola but not for the Bundibugyo strain currently causing the outbreak.
The World Health Organization stated it is not known whether Ervebo protects humans against the Bundibugyo virus. Al Jazeera noted no approved vaccine or treatment exists specifically for Bundibugyo.
Consequently, 20,000 of the doses are intended for a late-stage clinical trial to assess if Ervebo offers any cross-protection against the circulating strain.
The remaining 50,000 doses are designated for frontline and health workers in Congo. Funding for shipment and vaccination efforts is being provided by Gavi, the global vaccine alliance.
Official case and death tallies differ slightly between reports: The Hindu gave figures of 5,290 cases and 2,516 deaths, while Al Jazeera reported 5,208 cases and 2,476 deaths.
UN officials warned the outbreak is "growing exponentially." The Congolese government, with UN support, is scaling up its response, which includes expanding care capacity and community engagement.
2 independent outlets on this story. The thread also holds 28 filings over 6 weeks, which is more than this story alone attracted — it has collected neighbouring reports as well.
The arrival of 16,000 doses of Ervebo vaccine is driven by a high force the engine calls Directed Intelligence. This describes the global health community's focused action, deploying a specific, strongly supported tool against a known deadly threat: Ebola.
Two critically high antagonistic forces shape the challenge ahead. Cost & Friction measures the immense logistical difficulty of operating in a conflict-affected region with limited infrastructure. Adaptive Decay represents the system's load—the outbreak's natural tendency to spread and the strain on the health system.
This situation is also governed by a high force the engine calls the Interaction Field. This represents the social determinants of success, like community trust and local leadership, indicating the campaign's outcome depends on more than just biomedical tools. Finally, Feedback & Momentum is in a compounding loop; every successful vaccination strengthens trust and enables the next, while any failure fuels mistrust and slows progress.
The central forecast is cautious optimism, with containment the most likely outcome, but substantive risks remain. The forces favoring success are clear, but the antagonistic forces of logistical friction and systemic strain are critically high, making failure paths a combined 35% risk.
The next month will be decisive. Observers should watch for early signs of whether the Feedback & Momentum loop turns positive, with vaccines efficiently reaching target populations, or negative, as logistical hurdles or community resistance emerge and slow the response.
The Director of Public Health and Preventive Medicine says the caseload remains steady and is not of outbreak proportions; cases are being reported across cities including the Chennai belt (Tiruvallur and Kancheepuram), Coimbatore, and Madurai
The World Health Organization has recently raised the alarm regarding the rapid geographical spread of the virus into new health zones, stretching limited resources.
The researchers said the figures reflect total deaths and disability, meaning countries with larger populations may account for a greater share of the burden even if their rates are not the highest
Congo declared an end to mpox as a national public health emergency in April after a three-year outbreak that resulted in more than 34,000 confirmed cases nationwide. Authorities cautioned at the time that the virus had not been eradicated and could resurge
The institute has performed bone marrow transplants for patients with blood disorders and cancers, using autologous, matched family donor and half-matched transplants
The World Health Organization has in the meantime recommended the implementation of a phase three clinical trial using the Ervebo vaccine deployed against the Zaire strain
CLL is sometimes discovered by chance during a regular blood check, in particular if lymphocyte counts are abnormally high
More than 50,000 doses of the Ervebo vaccine have been received, according to Congo's state news agency
Sometimes incidental findings can cause unnecessary anxiety in patients who may believe that their spine is ‘damaged’ when in fact, the finding may simply be a normal part of ageing. Imaging that does not change treatment can therefore add cost, worry and sometimes unnecessary interventions
Mr. Singh said patients sometimes reached doctors not merely with their symptoms but with the diagnosis they had arrived at through internet searches
The Ervebo vaccine "has already been used several times, and in particular on a very large scale during the 2018-2020 outbreak", says Samuel Roger Kamba, the DRC's Minister of Health
Tavneos is made by the U.S. biotech firm Amgen and is sold by different partner pharmaceutical companies around the world
Researchers have for years been trying to apply mRNA treatments against cancer, but this was the first time such a drug showed positive results in a large, late-stage clinical trial
A systematic review of 34 studies found 53.3% of anti-TB prescriptions in non-programmatic settings were faulty, with substantial variation across States and an estimated 2–3 million potentially inappropriate prescriptions annually
In Visakhapatnam, women are finding new ways to work out, with kickboxing, music and community bringing strength training into the social space
Sarcomas, rare types of cancer, can often first appear as seemingly harmless lumps. Some are even operated on before a diagnosis is properly established. But a first operation performed without sarcoma-specific planning can make subsequent treatment more extensive
Former PM Imran Khan has been shifted back to Adiala Jail from Islamabad’s Shifa International Hospital, where he was admitted for treatment following a Supreme Court order
Wearing multiple hats from that of a house surgeon to a legislator, Dr. Muthulakshmi Reddy’s name stands tall among pioneers in history
Advances in AI are allowing scientists to mine vast amounts of genomic data to detect disease earlier, predict risk and tailor treatments to individuals. But at the heart of this lies an old, constant problem – the data used to build these tools lack diversity. South Asian scientists now want to
Former Prime Minister Imran Khan has been shifted from Adiala Jail to Shifa International Hospital in Islamabad following Supreme Court order, confirms Pakistan Tehreek-e-Insaf
WHO says vaccines for Ebola virus disease being allocated to DRC amid largest outbreak that has killed nearly 2,500.
ChatGPT for Teens, designed for 13 to 17-year-olds, has features such as parental controls, “quiet hours”, study mode, and notifications for situations that need real-world interventions
The understanding that mosquitoes could cause malaria and other diseases did more than solve a biological mystery. It completely changed disease control: drainage of stagnant water, environmental sanitation, mosquito nets, screening of houses and later, insecticides became important public
It found there was no sanitation service at more than one in 10 health facilities globally, serving 936 million people.
A former engineering director at Meta told jurors at a landmark trial that the company took a “don’t ask, don’t tell” approach on kids under 13 on its platforms
Curbs on surrogate advertising must avoid regulatory overreach
Sources are evidence, not content. Each keeps its own name, its own link and an extract capped at 400 characters; none of it is rewritten into the copy above.
